Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Dose Caffeine for Apnea of Prematurity
NCT04144712Phase 1Unknown
- Sponsor
- Ain Shams University
- Start
- Apr 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Ain Shams University. Primary endpoint: Rate of occurrence of Apnea of Prematurity. Status: unknown.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT04144712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04144712.